683 CAPITAL MANAGEMENT, LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:35 pm Sale | 2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | 683 CAPITAL MANAGEMENT, LLC | 90,000 0.200% | -1,842,829 (-95.34%) | Filing |
| 2022-02-11 6:39 pm Purchase | 2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | 683 CAPITAL MANAGEMENT, LLC | 1,932,829 5.300% | 111,680 (+6.13%) | Filing |